Loss of Cirbp expression is correlated with the malignant progression and poor prognosis in nasopharyngeal carcinoma

• Published in: Cancer management and research Vol. 11; pp. 6959 - 6969
• Main Authors: Lin, Tao-Yan, Chen, Yan, Jia, Jun-Shuang, Zhou, Chen, Lian, Mei, Wen, Yue-Ting, Li, Xiao-Yan, Chen, Heng-Wei, Lin, Xiao-Lin, Zhang, Xiao-Ling, Xiao, Sheng-Jun, Sun, Yan, Xiao, Dong
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.07.2019; Dove; Dove Medical Press
• Subjects: Analysis; Cancer; Carcinoma; Cirbp; E-cadherin; Immunohistochemistry; Ki67; nasopharyngeal carcinoma (NPC); Original Research; Prognosis; Protein binding; RNA; TNM stage; Tumors; China; nasopharyngeal carcinoma; NPC; TNM stage; Ki67; E-cadherin; prognosis; cirbp
• ISSN: 1179-1322; 1179-1322
• DOI: 10.2147/CMAR.S211389

The correlation of cold-inducible RNA-binding protein (Cirbp) expression with clinicopathological features including patient prognosis in nasopharyngeal carcinoma (NPC) was investigated. The expression of Cirbp in NPC cell lines and tissue specimens was examined by qRT-PCR or immunohistochemistry (IHC). Immunohistochemistry (IHC) results showed that high Cirbp expression was detected in 61 of 61 non-cancerous nasopharyngeal squamous epithelial biopsies, whereas the significantly reduced expression of Cirbp was observed in NPC specimens. In addition, IHC assay for Cirbp protein illustrated that the cells of 177 NPC samples and nasopharyngeal squamous epithlial cells displayed strong signals in nuclei and faint signals in cytoplasm, whereas Cirbp protein is mainly detected in the cell's cytoplasm in many other cancers. More importantly, TNM classification displayed that the low expression of Cirbp was more frequently observed in T3-T4, N2-N3, M1 and III-IV NPC biopsies, and undifferentiated carcinoma (UDC) than T1-T2, N0-N1, M0 and I-II tumors, and differentiated nonkeratinizing carcinoma (DNKC), suggesting that Cirbp loss is a key molecular event in advanced cases of NPC. Kaplan-Meier survival analysis indicated that NPC patients showing lower Cirbp expression had a significantly shorter overall survival time than those with high Cirbp expression. Multivariate analysis suggested that the level of Cirbp expression was an independent prognostic indicator for NPC survival. Finally, we revealed a significant positive association between Cirbp expression and E-cadherin, and a notable negative correlation between Cirbp expression and Ki67 labeling index in NPC biopsies. Collectively, these findings demonstrate that loss of Cirbp expression is correlated with malignant progression and poor prognosis in NPC.